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Editor’s key points
† Previously, continuous
cardiac output (CO)
measurement techniques
required the insertion of a
pulmonary artery
catheter.
† The PiCCO and
VolumeView systems use
arterial pulse contour
analysis for continuous
CO measurement.
† Both require calibration
with transpulmonary
thermodilution (TPTD)
measurements using a
central venous catheter.
† The current study
compared the
performance of PiCCO,
VolumeView, and TPTD
measurements.
Background. A new calibrated pulse wave analysis method (VolumeViewTM/EV1000TM,
Edwards Lifesciences, Irvine, CA, USA) has been developed to continuously monitor cardiac
output (CO). The aim of this study was to compare the performance of the VolumeView
method, and of the PiCCO2TM pulse contour method (Pulsion Medical Systems, Munich,
Germany), with reference transpulmonary thermodilution (TPTD) CO measurements.
Methods. This was a prospective, multicentre observational study performed in the surgical and
interdisciplinary intensive care units of four tertiary hospitals. Seventy-two critically ill patients
were monitored with a central venous catheter, and a thermistor-tipped femoral arterial
VolumeViewTM catheter connected to the EV1000TM monitor. After initial calibration by TPTD
CO was continuously assessed using the VolumeView-CCO software (CCOVolumeView) during a
72 h period. TPTD was performed in order to obtain reference CO values (COREF). TPTD and
arterial wave signals were transmitted to a PiCCO2TM monitor in order to obtain CCOPiCCO
values. CCOVolumeView and CCOPiCCO were recorded over a 5 min interval before assessment of
COTPTD. Bland–Altman analysis, %
errors, and concordance (trend analysis) were calculated.
Results. A total of 338 matched sets of data were available for comparison. Bias for
CCOVolumeView2COREF was 20.07 litre min
21 and for CCOPiCCO–COREF +0.03 litre min21.
Corresponding limits of agreement were 2.00 and 2.48 litre min21 (P,0.01), %errors 29 and
37%, respectively. Trending capabilities were comparable for both techniques.
Conclusions. The performance of the new VolumeViewTM-CCO method is as reliable as the
PiCCO2TM-CCO pulse wave analysis in critically ill patients. However, an improved precision
was observed with the VolumeViewTM technique.
Clinicaltrials.gov identifier. NCT01405040.
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Cardiac output (CO) assessment is a corner stone1 in
advanced haemodynamic management, especially in critic-
ally ill patients. Pulmonary artery thermodilution (PATD) has
been used as a standard method for this purpose for .20
years2 – 4 and is progressively being replaced in many patients
by less invasive monitoring techniques.5 6 One of these tech-
niques is continuous analysis of the arterial pressure wave-
form. Today, different companies provide a variety of
devices based on this method using different algorithms
for the estimation of CO. In general, pulse wave analysis
devices can be divided into un-calibrated and calibrated
monitoring systems; both can be adequately used in
dedicated settings and patient groups according to their lim-
itations and technical properties.7 Based on the fact that
there is no ‘perfect’ monitoring device, ongoing development
is required that may lead to improved measurements and
hence improved patient management.
Recently, a new pulse wave analysis system has been
developed and introduced into clinical practice that consists
of a specific thermistor-tipped arterial catheter (the
VolumeViewTM catheter) and the EV1000TM monitoring plat-
form (Edwards Lifesciences, Irvine, CA, USA). The system
uses a novel proprietary algorithm to continuously assess
CO based on the femoral arterial pressure curve signal and
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it uses TPTD for calibration.8 The modified TPTD algorithm
has been successfully evaluated recently in an animal
model9 and in critically ill patients.10 However, this system
has not yet been validated for continuous CO determination
against a reference method.
The aim of the present multi-centre clinical study was to
compare the new EV1000TM-VolumeViewTM and the
PiCCO2TM pulse contour methods (Pulsion Medical Systems,
Munich, Germany)11 – 13 with the reference TPTD technique
in a mixed population of critically ill patients.
Materials and methods
Patients
This prospective observational study was conducted in four
hospital centres in Germany and Switzerland (Aachen,
Bonn, Geneva and Zurich). The trial was registered at a
public registry (clinicaltrials.gov identifier: NCT01405040).
Approval from local institutional review boards at all partici-
pating institutions was obtained: (EthikKommission an der
Medizinischen Fakulta¨t der Rheinisch-Westfa¨lischen Tech-
nischen Hochschule Aachen, Aachen, Germany; Ethikkom-
mission an der Medizinischen Fakulta¨t der Rheinischen
Friedrich-Wilhelms-Universita¨t Bonn, Bonn, Germany; Com-
mission Centrale d’Ethique de la recherche sur l’eˆtre
humain, Hoˆpitaux Universitaires de Gene`ve, Gene`ve, Switzer-
land; Ethikkommission der beiden Stadtspita¨ler Triemli und
Waid, Kantonale Ethikkommission des Kantons Zu¨rich,
Zu¨rich, Switzerland).
All patients or their legal representatives gave written
informed consent. Patients who had been admitted to an in-
tensive care unit (ICU) and who the treating clinician thought
required advanced haemodynamic monitoring, were en-
rolled. Patients ,18 years or patients with a body weight
,40 kg were not eligible for the study. Other exclusion cri-
teria comprised significant aortic regurgitation, use of
intra-aortic balloon pump and participation in an investiga-
tional drug or device study interfering with endpoints of
this study and a known or potential pregnancy. All patients
were treated at the discretion of the ICU staff in charge;
there was no specific protocol for any intervention.
Devices and measurements
CO assessment was performed during a 72 h observation
period in all patients. A VolumeViewTM catheter (diameter:
5 Fr, length 20 cm; Edwards Lifesciences) was introduced
into the left or right femoral artery and connected to the
EV1000TM system which includes a panel interface and
data box (Edwards Lifesciences, software version 1.0). No
complications related to the femoral line during the study
period were observed.
Continuous CO was determined by pulse wave analysis
using the new VolumeView-CCO software (CCOVolumeView).
TPTD measurements were performed as sets of at least
three consecutive injections of 20 ml cold saline via a
central venous line, randomly distributed over the respiratory
cycle. A bolus was rejected and deleted by the observer,
usually the attending physician, when visual inspection of
the TPTD curve revealed artifacts, or a measurement error oc-
curred. Boluses were repeated until three valid thermodilu-
tion curves were obtained with a reproducibility ≤15%.
There was no regular time interval between two successive
measurements. All measurements were randomly spread
according to the attending physicians. Measurements were
performed during the regular ICU treatment of the patients
under different ventilator modalities (i.e. completely mechanic-
ally ventilated patients, spontaneously breathing patients with
and without ventilator support).
The mean CO value of the TPTD measurements was used
as the reference method (COREF). These data were electronic-
ally recorded at 500 Hz on the EV1000TM system and down-
loaded for analysis via a universal serial bus connection.
Later, arterial pressure data were delivered electronically as
real-time procedure into a PiCCO2TM monitor (Pulsion
Medical Systems, Munich, Germany) in order to obtain con-
tinuous PiCCO2TM pulse wave analysis CO values (CCOPiCCO)
and these data were also electronically recorded. This pro-
cedure is now used on a regular basis for the comparison
of different measurement techniques.14 15 Both pulse
contour methods were re-calibrated each time TPTD mea-
surements were done. CCOVolumeView and CCOPiCCO data for
statistical analysis were recorded during a 5 min interval
before assessment of COREF (i.e. just before the re-calibration
of CCOVolumeView and CCOPiCCO). These data, and measure-
ments recorded during a 5 min interval post assessment of
COREF, were also used to assess the corresponding changes
of CCOVolumeView, CCOPiCCO, and COREF; initial calibration data
at baseline were excluded from the analysis.
Pulse wave analysis algorithms
The pulse wave analysis algorithm for CCOVolumeView (i.e. the
EV1000TM monitoring platform), uses a proprietary ‘combin-
ation’ CCO algorithm:
CCOVolumeView = CO (TPTD)
× f (D conventional pulse-wave parameters,
D advanced wave shape parameters)
‘Conventional’ pulse-wave parameters are determined con-
sidering the fundamental work of Wesseling16 assuming
that the area under the systolic part of the pressure wave-
form is related to stroke volume by aortic impedance.
Further development based on a three-element ‘Windkessel’
model17 involved the assessment of the aortic impedance as
quotient of an un-calibrated pulse wave stroke volume and a
stroke volume derived by TPTD.18 Because only the systolic
portion of the pressure wave form is analysed, a detection
of the ‘notch’, the transition point after the systolic peak as
a result of the aortic valve closure is required. ‘Advanced’ ar-
terial pressure wave shape parameters, on the other hand,
are derived from analysis of the pressure waveform of the
entire heart cycle. An in-depth description of this method
can be found in a recent publication.19 In summary, the
advanced analysis relies primarily on the assessment of
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aortic compliance according to Langewouters and collea-
gues20 and dedicated waveform assessment, including skew-
ness calculations, where symmetry characteristics on arterial
pressure indicates a change in vascular tone and resistance,
and kurtosis calculations, where the measurement of the di-
vergence from a normally distributed wave is associated with
large vessel compliance.
The pulse wave analysis algorithm for CCOPiCCO, on the
other hand, is an algorithm based only on the ‘conventional’
pulse-wave parameters described above. Details have been
previously described.12 13 The principles of TPTD calibration
measurements have also been described in detail else-
where.8 9
Statistics
Statistical calculation was performed using the R software
(Version 2.11.1, a free software environment for statistical
computing; http://www.r-project.org). Linear regression,
Bland–Altman analysis21 including % error calculation22
were done in order to compare absolute CCOVolumeView and
CCOPiCCO with COREF values. Concordance analysis
23 was per-
formed as trend analysis for changes of CCOVolumeView and
CCOPiCCO when compared with changes of COREF; an exclusion
zone of 15% was applied as recommended recently.23 Statis-
tical significance was set at a P-value of ,0.05. Results are
expressed as mean [standard deviation (SD)].
Results
The study was mainly performed in patients who had under-
gone cardiac surgery. Biometric and socio-demographic data
of the 72 patients enrolled in this study are presented in
Table 1. Sixty-one patients were undergoing mechanical ven-
tilation. For these patients a total of 338 matched sets of
data during a time window of 72 h were collected and ana-
lysed. The study period was 34.5 (20.9) h [mean (SD)], range
5.4–72 h. Regarding the number of boluses, 3.6 (1.1)
[mean (SD)], range 1–6, were used per CO measurement,
with only 3.7% of the thermodilution sets rejected because
of a reproducibility .15%.
CO data are summarized in Table 2. A broad range of CO
values for all measurement techniques (i.e. CCOVolumeView,
CCOPiCCO, and COREF) was observed with a comparable
mean CO for all measurement techniques. Mean changes
of CO and the corresponding range were 5.2 (3.8) litre
min21 (0–14.3) for CCOVolumeView, 5.3 (3.8) litre min
21 (0–
14.9) for CCOPiCCO, and 6.4 (4) litre min
21 (0–15) for COREF.
Mean arterial pressure during the study period was 10.1
(0.13) kPa (range: 43–114) and a mean systemic vascular re-
sistance was 839 (286) dyn s cm25 ranging from 273 to 1940
dyn s cm25.
Comparing CCOVolumeView, and CCOPiCCO with COREF
revealed a low mean bias in the Bland–Altman analysis
(Table 2, Fig. 1) that was comparable for both continuous
measurement techniques. The precision, defined as SD of
the mean bias, was better when comparing CCOVolumeView
with COREF than when comparing CCOPiCCO with COREF
(P,0.01). A high coefficient of correlation (Table 2) for both
techniques was found when compared with the reference
technique, no statistical difference could be detected
between correlation coefficients. Trend analysis for both
techniques was comparable considering concordance ana-
lysis (Table 2, Fig. 2).
Discussion
This prospective, multi-centric clinical study demonstrates
that the assessment of continuous CO in a critically ill
patient population using a new pulse wave analysis algo-
rithm implemented in the VolumeViewTM-EV1000TM monitor-
ing platform can be characterized as being as accurate as the
established calibrated pulse wave analysis device, the
PiCCO2TM method. Moreover, based on the presented data,
the new technique showed an improved precision when
compared with the established method.
The CCO-VolumeViewTM algorithm can be characterized as
‘improvement’ of the classic algorithm established and modi-
fied by Wesseling16 18 that is also being used of the PiCCO2TM
system. The ‘improvement’ process consisted of the addition-
al consideration of an advanced pressure waveform ana-
lysis.19 This creates potential advantages for the new
combination algorithm. The classic Wesseling algorithm
requires ‘only’ the systolic interval of the pressure curve for
CO assessment assuming constant aortic properties. This al-
gorithm proved to be susceptible for changes in the vascular
system with a limited accuracy of CO assessment.24 Taking a
dynamic interaction between cardiac function and aortic
compliance (i.e. aortic impedance) into account resulted in
an improved performance.11 – 13 However, for accurate mea-
surements a reliable detection of the end of the systole—
the ‘notch’—is required, which is not always given in daily
practice and in these situations an assumption has to be
made when the systole ends. It can be argued that the
advanced waveform analysis implemented in the new
‘hybrid’ algorithm may overcome this problem in part as
Table 1 Patient characteristics and indications for ICU admission.
ARDS, acute respiratory distress syndrome; BMI, body mass index;
F/M, female/male; ICU, intensive care unit; ‘Other’ includes
respiratory failure and intracranial bleeding
Sociodemographic
Age Years (range) 66 (25–81)
F/M ratio n/n 21/51
Weight kg (SD) 82 (20)
Height cm (SD) 172 (8)
BMI kg m22 (SD) 28 (1.3)
ICU admissions
Cardiac surgery n (%) 40 (55.6)
Non-cardiac surgery n (%) 4 (5.6)
Sepsis n (%) 7 (9.7)
ARDS n (%) 3 (4.2)
Other n (%) 18 (25)
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both the systolic and the diastolic waveform portion are
assessed. This may better reflect the actual conditions of
the cardiovascular system that includes diastolic issues of
the aortic Windkessel function,17 diastolic wave reflection
and the aortic-femoral pulse coupling.25 In this regard, it is
important to note that all pulse contour methods should
be affected by this physiological phenomenon. Considering
the results of the actual study (i.e. the improved precision)
it can be argued that the combination of two methods
resulted in a more robust algorithm able to capture acute
changes in vascular tone. However, previous studies have
already demonstrated that CO measurements using
advanced waveform computation are less precise and less
accurate in patients presenting vasoplegic states.26 And
even if, in the present study, patients SVR ranged from 273
to 1940 dyn s cm25, further study should be performed to
evaluate the present CCO-VolumeViewTM algorithm in vaso-
plegic patients.
In contrast to the PiCCO2TM algorithm the CCO—
VolumeViewTM algorithm met the so-called Critchley criteria
of an acceptable %error of ,30%,22 but it should be empha-
sized that this widely used %error threshold has been ques-
tioned recently by Peyton and colleagues.26 In their large
meta-analysis they demonstrated that no group of the min-
imally invasive haemodynamic monitoring systems (i.e. pulse
wave analysis, Doppler, Bioimpedance, and applied Fick prin-
ciple) met the set %error threshold and therefore it has been
argued that for clinical purposes a higher %error should be
accepted based on the technical limitations of all CO meas-
urement techniques. On the other hand, it is often assumed
that the ability to reliably track CO changes is more import-
ant than the assessment of absolute CO values23 and in
the present study both algorithms showed comparable
trending capabilities but failed to meet the goals of an ac-
ceptable concordance as proposed by Critchley and collea-
gues.23 The concordance analysis for CO trend assessment
is clearly an improvement in the evaluation of CO monitoring
devices, but a major problem is the lack of ability of the ad-
justment for repeated measurements and the potential bias
that may limit the informative value of this test. Pulse wave
Table 2 CO measurements and comparative analyses. CCOVolumeView, continuous cardiac output assessed by the new VolumeViewTM/EV1000TM
monitoring platform; COREF, cardiac output determined by TPTD; CCOPiCCO, continuous cardiac output assessed by the PiCCO2TM system. NA, not
available; SD, standard deviation; LoA, limits of agreement (¼2 SD)
Mean (SD) (litre min21) Mean bias (LoA) (litre min21) Error (%) Correlation, r ′′ Concordance (%)
CCOVolumeView 6.7 (2.3) (2.5–15.3) CCOVolumeView2COREF 20.1 (2.0) 29 0.83 81
CCOPiCCO 6.8 (2.5) (2.5–16.2) CCOPiCCO2COREF +0.1 (2.5) 37 0.76 77
CCOREF 6.8 (2.4) (2.7–18.6) CCOVolumeView2CCOPiCCO 20.1 (2.1) 31 0.82 NA
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analysis devices in general have gained greater interest for
continuous CO measurement recently6 and are increasingly
being applied in different patient settings today (e.g.
un-calibrated systems based on radial arterial signal primar-
ily for the management of perioperative goal-directed
therapy)27 and systems based on a femoral signal that are
calibrated by TPTD for the haemodynamic management of
ICU patients. This can be attributed to the fact, that most
of these devices can be easily handled, adequately used
without major operator interference and that they provide
‘real time’ continuous CO28 and functional haemodynamic
parameters such as stroke volume variation.29 However,
despite the importance of further improvements of the algo-
rithms optimal signal quality is a major prerequisite for reli-
able CO assessment and major limitations need to be
taken into account that include use of intra-aortic balloon
pump and major arrhythmias. Clearly, modern algorithms
may detect single ventricular extrasystoles and may
exclude them for CO assessment. However, the performance
of pulse wave analysis during absolute arrhythmia may limit
their use.6 In recent years research and development has
focused on non-calibrated pulse wave analysis devices and
subsequent validation identified appropriate areas of appli-
cation, but it also revealed the limits of the devices. A
major issue is definitely the fact that limited accuracy may
occur in situations of major changes and extremes of individ-
ual vascular tone. It has to be emphasized that these vascu-
lar tone effects may influence the performance of all pulse
wave devices, if they have to be calibrated or not, to a
various degree as this was observed in different studies.30 – 33
These effects may largely depend on the robustness of the
algorithms and for the un-calibrated devices on their under-
lying electronic databases that comprise nomograms and in-
formation of the different vascular conditions.6 In contrast,
calibrated pulse wave analysis techniques such as the
VolumeViewTM/EV1000TM and the PiCCO2TM system permit
an individual initial assessment of the cardiovascular condi-
tion by the calibration via TPTD, and when major haemo-
dynamic instability (i.e. considerable changes in vascular
tone) occurs, re-calibration allows for a situational adjust-
ment, a ‘re-setting’ of continuous CO assessment.34 More-
over, when general limitations for the use of pulse wave
analysis devices are present, intermittent TPTD can still be
used for reliable CO determination and thirdly, TPTD provides
additional haemodynamic parameters such as global end-
diastolic volume (GEDV) and extravascular lung water
(EVLW). GEDV has shown in recent years to be a superior
indicator of cardiac preload than standard pressure
parameters35 36 and EVLW can be useful in the treatment of a
pulmonary oedema or acute respiratory distress syndrome37 38
and as a prognostic marker in critically ill patients.39
The following limitations need to be considered when
interpreting the data of the actual study: TPTD was used as
a reference technique and not as an independent CO meas-
urement technique such as an aorta Doppler probe or PATD.
However, given the fact that there is no gold standard for CO
measurements it seems to be reasonable to use TPTD, which
has been shown to provide CO measurements as accurate as
the PATD.40 Moreover, CCO was not simultaneously assessed
by two different devices connected to two different femoral
arterial lines but directly to only one device, the
VolumeViewTM/EV1000TM and the data were then transmit-
ted to the PiCCO2TM monitor. However, this approach can
be considered acceptable for technical and ethical reasons
and is frequently used.14 15 Furthermore, this study was not
designed to specifically assess the CCO performance during
massive haemodynamic instability and major changes of
vascular tone in a mixed ICU patient population with a pre-
dominant set of patients after cardiac surgery. Thus, our
results must be interpreted within the context of the
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chosen setting as it is very difficult to make clear the
expected results in patients with highly variable vascular
tone, sudden changes in CO and needing vasoactive drugs.
Conclusions
In conclusion, in a mixed ICU population and a wide range of
clinical situations the new VolumeViewTM-CCO method per-
formed as accurately as the PiCCO2TM-CCO pulse wave ana-
lysis. Furthermore, an improved precision was observed for
the VolumeViewTM technique.
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